Bedel Financial Consulting’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-151
Closed -$15K 808
2019
Q3
$15K Sell
151
-500
-77% -$47.5K 0.01% 428
2019
Q2
$60K Hold
651
0.04% 258
2019
Q1
$61K Buy
651
+100
+18% +$8.75K 0.04% 248
2018
Q4
$35K Hold
551
0.03% 294
2018
Q3
$46K Buy
551
+400
+265% +$35.3K 0.03% 281
2018
Q2
$12K Hold
151
0.01% 462
2018
Q1
$13K Buy
+151
New +$14.5K 0.01% 445

Other funds holding CELG

Bedel Financial Consulting's CELG Position: Q4 2019 in Review

Bedel Financial Consulting sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 151 shares — an estimated $15K sold.

Bedel Financial Consulting first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $61K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bedel Financial Consulting reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bedel Financial Consulting sold 151 Celgene Corp shares in Q4 2019, an estimated $15K.
  • Bedel Financial Consulting first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Bedel Financial Consulting's Celgene Corp position peaked at $61K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bedel Financial Consulting's 13F filing for Q4 2019, filed 28 Jan 2020.